Zühre KAYA, Ülker KOÇAK, Şebnem SOYSAL, Elif KELEŞ GÜLNERMAN, Yağmur ÇAM, İdil YENİCESU, Bülent ELBASAN

The contribution of neurocognitive situation, physical capacity and daily life activities to quality of life in childhood acute lymphoblastic leukemia survivors

Background/aim: There are no extensive studies on the QL in children who completed acute lymphoblastic leukemia (ALL) treatment and currently living without any disease in Turkey. Our study aimed to analyze both the QL and the effects of physical, neurocognitive capacities on QL in childhood ALL survivors aged 7–12 years at the time of recruitment. Materials and methods: PedsQL cancer module 3.0 child and proxy report, for ages 5–7 and 8–12 years, WeeFIM scale, BOTMP Short Form, RPM, reading, writing, and mathematics assessment tools, sociodemographic information form were carried out to the children and their family. Results: There was no effect of the months since the completion of therapy on pain, anxiety, cognitive problems, perceived physical appearance, and the total QL scores of children and proxy reports (p > 0.05). Children’s physical capacities were significantly worse than healthy controls and have not reached the level of healthy children even after a long time since completion of ALL therapy. There was a significant association between physical capacity and daily independent living status (p < 0.001). Reading, writing, and mathematical skills were significantly associated with the mean time off-treatment (p < 0.001), and the total score of RPM and PedsQL of those with mathematical difficulties were significantly lower than those without any difficulty (p < 0.05). Conclusion: The months after the treatment (off-treatment time) have not affected total and subunit QL scores. As motor skills difficulties will lead to low academic achievement, early recognition could direct the parents for immediate intervention. Planning psychosocial support programs for physical activity and age-appropriate development of patients from the initiation of treatment will increase the QL in childhood ALL with a survival rate of 80% or more.Key words: ALL, QL, neurocognitive and physical outcome

PDF

___

1. Kaatsch P. Epidemiology of childhood cancer. Cancer Treatment Reviews 2010; 36 (4): 277-285. doi: 10.1016/j.ctrv.2010.02.003
2. Pickard AS, Topfer LA, Feeny DH. A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia. JNCI Monographs 2004; 2004 (33): 102-125. doi: 10.1093/jncimonographs/lgh002
3. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL et al. Cancer treatment and survivorship statistics, 2016. CA: Cancer Journal for Clinicians 2016; 66 (4): 271-289. doi: 10.3322/ caac.21349
4. Reinfjell T, Lofstad GE, Veenstra M, Vikan A, Diseth TH. Healthrelated quality of life and intellectual functioning in children in remission from acute lymphoblastic leukaemia. Acta Paediatrica 2007; 96 (9): 1280-1285. doi: 10.1111/j.1651-2227.2007.00383.x
5. Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL™ in pediatric cancer: reliability and validity of the pediatric quality of life inventory™ generic core scales, multidimensional fatigue scale, and cancer module. Cancer 2002; 94 (7): 2090-2106. doi: 10.1002/cncr.10428
6. Tur BS, Küçükdeveci AA, Kutlay Ş, Yavuzer G, Elhan AH et al. Psychometric properties of the WeeFIM in children with cerebral palsy in Turkey. Developmental Medicine & Child Neurology 2009; 51 (9): 732-738. doi: 10.1111/j.1469- 8749.2008.03255.x
7. Bruininks-Oseretsky R. Test of motor proficiency: Examiner’s manual. Circle Pines, MN: American Guidance Service. 1978.
8. Raven J. The Raven’s progressive matrices: change and stability over culture and time. Cognitive psychology 2000; 41 (1): 1-48. doi: 10.1006/cogp.1999.0735
9. Turan ST, Bakar EE, Erden G, Karakaş S. Using neuropsychometric measurements in the differential diagnosis of specific learning disability. Nöro Psikiyatri Arşivi 2016; 53 (2): 144-151. doi: 10.5152/npa.2015.10024
10. Baytan B, Aşut Ç, Kantarcıoğlu AÇ, Evim MS, Güneş AM. Health-related quality of life, depression, anxiety, and selfimage in acute lymphocytic leukemia survivors. Turkish Journal of Hematology 2016; 33 (4): 326-330. doi: 10.4274/ tjh.2015.0356
11. Kızmazoğlu D, Sarı S, Sezgin ME, Kantarcıoğlu A, Tüfekçi Ö et al. Assessment of health-related quality of life in pediatric acute lymphoblastic leukemia survivors: perceptions of children, siblings, and parents. Turkish Journal of Hematology 2019; 36 (2): 112-116. doi: 10.4274/tjh.galenos.2018.2018.0351
12. Sitaresmi MN, Mostert S, Gundy CM, Veerman AJ. Healthrelated quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health and Quality of Life Outcomes 2008; 6 (1): 1-8. doi: 10.1186/1477-7525-6-96
13. Sung L, Yanofsky R, Klaassen RJ, Dix D, Pritchard S et al. Quality of life during active treatment for pediatric acute lymphoblastic leukemia. International Journal of Cancer 2011; 128 (5): 1213-1220. doi: 10.1002/ijc.25433
14. Vlachioti E, Matziou V, Perdikaris P, Mitsiou M, Stylianou C et al. Assessment of quality of life of children and adolescents with cancer during their treatment. Japanese Journal of Clinical Oncology 2016; 46 (5): 453-461. doi: 10.1093/jjco/hyw009
15. Furlong W, Rae C, Feeny D, Gelber RD, Laverdiere C et al. Health-related quality of life among children with acute lymphoblastic leukemia. Pediatric Blood & Cancer 2012; 59 (4): 717-724. doi: 10.1002/pbc.24096
16. Mitchell HR, Lu X, Myers RM, Sung L, Balsamo LM et al. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: results of children’s Oncology group study AALL0331. International Journal of Cancer 2016; 138 (2): 332-339. doi: 10.1002/ijc.29708
17. Tsuji N, Kakee N, Ishida Y et al. Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) cancer module. Health and Quality of Life Outcomes. 2011; 9 (1): 1-6. doi: 10.1186/1477-7525-9-22
18. Huijer HA, Sagherian K, Tamim H. Quality of life and symptom prevalence as reported by children with cancer in Lebanon. European Journal of Oncology Nursing 2013;17 (6): 704-710. doi: 10.1016/j.ejon.2013.09.004
19. Eiser C, Vance YH, Horne B, Glaser A, Galvin H. The value of the PedsQLTM in assessing quality of life in survivors of childhood cancer. Child: Care, Health and Development 2003; 29 (2): 95-102. doi: 10.1046/j.1365-2214.2003.00318.x
20. Kirchhoff AC, Leisenring W, Krull KR, Ness KK, Friedman DL et al. Unemployment among adult survivors of childhood cancer: a report from the childhood cancer survivors study. Medical Care 2010; 48 (11): 1015-1025. doi: 10.1097/ MLR.0b013e3181eaf880
21. Kunin-Batson A, Kadan-Lottick N, Neglia JP. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia. Psycho-oncology 2014; 23 (6): 692-699. doi: 10.1002/pon.3470
22. Green JL, Knight SJ, McCarthy M, De Luca CR. Motor functioning during and following treatment with chemotherapy for pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer 2013; 60 (8): 1261-1266. doi: 10.1002/pbc.24537
23. Grimshaw SL, Taylor NF, Mechinaud F, Shields N. Assessment of physical function in children with cancer: a systematic review. Pediatric Blood & Cancer 2018; 65 (12): e27369. doi: 10.1002/pbc.27369
24. Hartman A, Te Winkel ML, Van Beek RD, De Muinck Keizer-Schrama SM, Kemper HC et al. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer 2009; 53 (1): 64-71. doi: 10.1002/ pbc.21942
25. Jansen NC, Kingma A, Schuitema A, Bouma A, Veerman AJ, Kamps WA. Neuropsychological outcome in chemotherapyonly–treated children with acute lymphoblastic leukemia. Journal of Clinical Oncology 2008; 26 (18): 3025-3030. doi: 10.1200/JCO.2007.12.4149
26. Kabak VY, Yakut Y, Çetin M, Düger T. Reliability and validity of the Turkish version of the PedsQL 3.0 cancer module for 2-to 7-year-old and the PedsQL 4.0 generic core scales for 5-to 7-year-old: the Hacettepe university experience. Turkish Journal of Hematology 2016; 33 (3): 236-243. doi: 10.4274/ tjh.2015.0242
27. Tanir MK, Kuguoglu S. Turkish validity and reliability of a pediatric quality of life cancer module for children aged 8-12 and parents. Asian Pacific Journal of Cancer Prevention 2011; 12 (1): 125-130.